Does OBINUTUZUMAB Cause Erythema? 96 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 96 reports of Erythema have been filed in association with OBINUTUZUMAB (Gazyva). This represents 0.7% of all adverse event reports for OBINUTUZUMAB.
96
Reports of Erythema with OBINUTUZUMAB
0.7%
of all OBINUTUZUMAB reports
11
Deaths
46
Hospitalizations
How Dangerous Is Erythema From OBINUTUZUMAB?
Of the 96 reports, 11 (11.5%) resulted in death, 46 (47.9%) required hospitalization, and 4 (4.2%) were considered life-threatening.
Is Erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OBINUTUZUMAB. However, 96 reports have been filed with the FAERS database.
What Other Side Effects Does OBINUTUZUMAB Cause?
Off label use (1,584)
Neutropenia (1,276)
Febrile neutropenia (955)
Covid-19 (942)
Pyrexia (920)
Thrombocytopenia (889)
Disease progression (831)
Infusion related reaction (789)
Pneumonia (662)
Anaemia (640)
What Other Drugs Cause Erythema?
ADAPALENE (38,965)
AVOBENZONE\OCTISALATE\OCTOCRYLENE (30,872)
DUPILUMAB (10,877)
ADALIMUMAB (4,829)
ETANERCEPT (3,733)
AVOBENZONE\HOMOSALATE\OCTINOXATE\OCTISALATE\OXYBENZONE (3,462)
INFLIXIMAB (2,919)
METHOTREXATE (2,835)
SECUKINUMAB (2,824)
RITUXIMAB (2,460)
Which OBINUTUZUMAB Alternatives Have Lower Erythema Risk?
OBINUTUZUMAB vs OCELLA
OBINUTUZUMAB vs OCRELIZUMAB
OBINUTUZUMAB vs OCRIPLASMIN
OBINUTUZUMAB vs OCTINOXATE\OCTISALATE\ZINC
OBINUTUZUMAB vs OCTINOXATE\OCTOCRYLENE